Samuel Tracy

654 total citations
15 papers, 495 citations indexed

About

Samuel Tracy is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Samuel Tracy has authored 15 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Samuel Tracy's work include Lymphoma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (5 papers) and CAR-T cell therapy research (4 papers). Samuel Tracy is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (5 papers) and CAR-T cell therapy research (4 papers). Samuel Tracy collaborates with scholars based in United States, Canada and Germany. Samuel Tracy's co-authors include Ana M. Borras, Xiao‐Jun Zhao, Bruce E. Johnson, J. A. Engelman, Eugene Lifshits, Kreshnik Zejnullahu, Jing Sun, Toru Mukohara, George N. Naumov and Lewis C. Cantley and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Samuel Tracy

14 papers receiving 488 citations

Peers

Samuel Tracy
Lini Pandite United States
Paula J. Spitzler United States
Tahsin M. Khan United States
Greg J. Riely United States
Magda Bahcall United States
Azusa Tanimoto Japan
Hielke J. Meulenbeld Netherlands
Yun Fan China
Chiara Bennati Italy
Lyudmila Bazhenova United States
Lini Pandite United States
Samuel Tracy
Citations per year, relative to Samuel Tracy Samuel Tracy (= 1×) peers Lini Pandite

Countries citing papers authored by Samuel Tracy

Since Specialization
Citations

This map shows the geographic impact of Samuel Tracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Tracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Tracy more than expected).

Fields of papers citing papers by Samuel Tracy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Tracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Tracy. The network helps show where Samuel Tracy may publish in the future.

Co-authorship network of co-authors of Samuel Tracy

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Tracy. A scholar is included among the top collaborators of Samuel Tracy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Tracy. Samuel Tracy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Budde, Lihua E., Matthew J. Matasar, Laurie H. Sehn, et al.. (2024). Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1646–1646. 4 indexed citations
3.
4.
Herrera, Alex F., Samuel Tracy, Laurie H. Sehn, et al.. (2023). CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY. Hematological Oncology. 41(S2). 175–177. 1 indexed citations
5.
Morschhauser, Franck, Wilfred Leung, Vibha Raghavan, et al.. (2023). Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study. Blood. 142(Supplement 1). 3000–3000. 10 indexed citations
6.
Herrera, Alex F., Samuel Tracy, Laurie H. Sehn, et al.. (2023). Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.. Journal of Clinical Oncology. 41(16_suppl). 7523–7523. 3 indexed citations
7.
Jardin, Fabrice, Vibha Raghavan, Samuel Tracy, et al.. (2023). Plasma Circulating Tumor DNA (ctDNA) as an Alternative to Tissue DNA for Genotyping of DLBCL: Results from the POLARIX Study. Blood. 142(Supplement 1). 169–169. 2 indexed citations
8.
Paulson, Joseph N., Martin Hutchings, Lale Kostakoglu, et al.. (2022). Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments. Cancer Imaging. 22(1). 39–39. 18 indexed citations
9.
Herrera, Alex F., Ronald McCord, Patrick K. Kimes, et al.. (2022). Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study. Blood. 140(Supplement 1). 1297–1300. 13 indexed citations
10.
11.
Herrera, Alex F., Samuel Tracy, Stephen Opat, et al.. (2022). Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA. Blood Advances. 6(6). 1651–1660. 22 indexed citations
12.
Tracy, Samuel, et al.. (2021). OptBand: optimization-based confidence bands for functions to characterize time-to-event distributions. Lifetime Data Analysis. 27(3). 481–498.
13.
Choi, Daniel S., et al.. (2020). Development and validation of a novel prediction score for cardiac tamponade in emergency department patients with pericardial effusion. European Heart Journal Acute Cardiovascular Care. 10(5). 542–549. 3 indexed citations
14.
Tracy, Samuel, Guo‐Cheng Yuan, & Ruben Dries. (2019). RESCUE: imputing dropout events in single-cell RNA-sequencing data. BMC Bioinformatics. 20(1). 388–388. 30 indexed citations
15.
Engelman, J. A., Toru Mukohara, Kreshnik Zejnullahu, et al.. (2006). Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. Journal of Clinical Investigation. 116(10). 2695–2706. 374 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lini Pandite Breakdown of academic impact, for papers by Paula J. Spitzler Breakdown of academic impact, for papers by Tahsin M. Khan Breakdown of academic impact, for papers by Greg J. Riely Breakdown of academic impact, for papers by Magda Bahcall Breakdown of academic impact, for papers by Azusa Tanimoto Breakdown of academic impact, for papers by Hielke J. Meulenbeld Breakdown of academic impact, for papers by Yun Fan Breakdown of academic impact, for papers by Chiara Bennati Breakdown of academic impact, for papers by Lyudmila Bazhenova
Rankless by CCL
2026